BackConduit Pharmaceuticals Overview

Conduit Pharmaceuticals Operating Income

Operating Income for CDT.

Quarterly Operating Income

$77.96M
↑ 7.34% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$564.78M
↑ 164.69% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin